Neurodiagnostics Market Overview
According to MRFR analysis, the Global Neurodiagnostics Market overview report is expected to register a CAGR of 7% from 2023 to 2030 and held a value of USD 4,848.48 Million in 2018.
Neurodiagnostic tests which are also known as neurodiagnostics. records and monitors electrical activities of the patient's peripheral nerves, spinal cord, and brain. These tests help physicians to confirm or rule out a neurological disorder or other medical condition. The growth of the global neurodiagnostics market is boosted by factors such as rising number of strategic initiatives by key players such as mergers, joint ventures, acquisitions, partnerships, coupled with the advancements in technology across the globe. Furthermore, many non-profit organizations in various countries are working towards creating awareness regarding neurological diseases. For instance, the World Federation of Neurology (WFN), founded in July 2016, is a membership organization focused on raising awareness about the age and neurological conditions and diseases associated with age.
However, the high cost of neurodiagnostic treatment is likely to restrain the market growth to a certain extent in the coming years.
Market players such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Hitachi, Ltd., currently dominate the global neurodiagnostics market. The key players are involved in product launches and agreements to strengthen their market positions. For instance, in December 2019, GE Healthcare (US), signed USD 100 million technology partnership agreement with AFFIDEA (Ireland). GE Healthcare will install 200+ new equipment in Affidea’s network of centers across Europe. The deal includes the provision of 60 new MRIs, 50 ultrasound devices, 40 CT scanners and 30 X-rays machines in the next 3 years. It also includes a six-year service contract.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East Africa. The Americas held maximum share in the base year 2018, owing to the high incidence rates of neurological disorders in countries such as US. According to the American Neurological Association, as of 2016, mealy 100 million Americans were affected by at least one of the neurological diseases. The neurodiagnostics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European neurodiagnostics market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The neurodiagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The neurodiagnostics market in this region is anticipated to be the fastest-growing during the assessment period due to the increasing awareness about the diagnostic treatments and favorable reimbursement policies. The neurodiagnostics market in the Middle East Africa has been divided into the Middle East and Africa.
Segmentation
The Global Neurodiagnostics Market share report has been segmented based on Product, Condition, and End User.
The market, based on product type, has been divided into diagnostic imaging systems, clinical diagnostic instruments, and reagents consumables. The diagnostic imaging systems segment held a major share in 2018 owing to the rising number of diagnostic laboratories an imaging centers in the developing as well as developed countries. The reagents consumables was the fastest-growing segment in 2018 due to high consumption in various routine techniques. The market, based on diagnostic imaging systems, has been further segment is segmented as, MRI systems, EEG systems, CT scanners, PET scanners, EMG devices, ultrasound imaging systems, MEG devices, angiography systems, and others. The market, based on clinical diagnostic instruments has been further bifurcated into PCR instruments, NGS instruments, sanger sequencers, and others. The market, based on reagents consumables has been further segmented into media sera, antibodies, buffers, solvents, enzymes, proteins, peptides, probes, and other.
The global neurodiagnostics market has been segmented, based on the condition, into neurodegenerative diseases, stroke, epilepsy, headache disorders, sleep disorders, and others. In 2018, stoke segment held the majority share of the market owing to the growing geriatric population. The neurodegenerative diseases segment is anticipated to be the fastest growing during the forecast period due to the high number of Parkinson’s and Alzheimer’s disease population.
The global neurodiagnostics market, based on end user, has been segmented into hospitals surgical centers, diagnostic laboratories imaging centers, neurology centers, ambulatory care centers, and research laboratories academic institutes. The hospitals surgical centers segment held the maximum share in 2018 owing to its high purchasing power to buy expensive equipment. The neurology centers segment is expected to be the fastest-growing during the assessment period due to the lower cost and short waiting period compared to hospitals.
Key Players
Some of the key players in the global neurodiagnostic market are GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Thermo Fisher Scientific, Inc. (US), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), and QIAGEN N.V. (Netherlands).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
